Japan · Delayed Price · Currency is JPY Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 845.85 billion. The enterprise value is 849.19 billion.
| Market Cap | 845.85B |
| Enterprise Value | 849.19B |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Organo has 45.98 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 21.53% |
| Float | 24.62M |
Valuation Ratios
The trailing PE ratio is 29.78 and the forward PE ratio is 27.05.
| PE Ratio | 29.78 |
| Forward PE | 27.05 |
| PS Ratio | 4.76 |
| PB Ratio | 5.92 |
| P/TBV Ratio | 5.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.90 |
| EV / Sales | 4.78 |
| EV / EBITDA | 21.34 |
| EV / EBIT | 22.46 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.71 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | n/a |
| Interest Coverage | 126.34 |
Financial Efficiency
Return on equity (ROE) is 21.50% and return on invested capital (ROIC) is 19.47%.
| Return on Equity (ROE) | 21.50% |
| Return on Assets (ROA) | 11.22% |
| Return on Invested Capital (ROIC) | 19.47% |
| Return on Capital Employed (ROCE) | 24.46% |
| Weighted Average Cost of Capital (WACC) | 10.84% |
| Revenue Per Employee | 66.84M |
| Profits Per Employee | 10.69M |
| Employee Count | 2,658 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 5.48 |
Taxes
In the past 12 months, Organo has paid 9.91 billion in taxes.
| Income Tax | 9.91B |
| Effective Tax Rate | 25.86% |
Stock Price Statistics
The stock price has increased by +125.98% in the last 52 weeks. The beta is 1.27, so Organo's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +125.98% |
| 50-Day Moving Average | 16,168.10 |
| 200-Day Moving Average | 14,259.78 |
| Relative Strength Index (RSI) | 67.69 |
| Average Volume (20 Days) | 282,530 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 177.65 billion and earned 28.40 billion in profits. Earnings per share was 617.74.
| Revenue | 177.65B |
| Gross Profit | 65.08B |
| Operating Income | 37.65B |
| Pretax Income | 38.31B |
| Net Income | 28.40B |
| EBITDA | 39.63B |
| EBIT | 37.65B |
| Earnings Per Share (EPS) | 617.74 |
Balance Sheet
The company has 31.06 billion in cash and 34.40 billion in debt, with a net cash position of -3.35 billion or -72.79 per share.
| Cash & Cash Equivalents | 31.06B |
| Total Debt | 34.40B |
| Net Cash | -3.35B |
| Net Cash Per Share | -72.79 |
| Equity (Book Value) | 142.96B |
| Book Value Per Share | 3,109.02 |
| Working Capital | 121.06B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.93B |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 36.64%, with operating and profit margins of 21.19% and 15.99%.
| Gross Margin | 36.64% |
| Operating Margin | 21.19% |
| Pretax Margin | 21.56% |
| Profit Margin | 15.99% |
| EBITDA Margin | 22.31% |
| EBIT Margin | 21.19% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 220.00, which amounts to a dividend yield of 1.26%.
| Dividend Per Share | 220.00 |
| Dividend Yield | 1.26% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | 1.35% |
| Earnings Yield | 3.36% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Organo is 20,450.00, which is 11.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 20,450.00 |
| Price Target Difference | 11.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 9.20% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 6.6 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.6 |
| Piotroski F-Score | 4 |